Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

Mumbai: Softening prices of active pharmaceutical ingredients (API) are likely to stabilise in the months ahead and bring relief to Indian manufacturers, but they will still have to improve their ...

In order to give a booster shot to the production and improving the quality of active pharmaceutical ingredients (APIs) as well as for reducing the costly imports from China, the Union government is ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

As a precursor to the planned high-level interaction under the leadership of Hon’ble Chief Minister of Himachal Pradesh, Shri Sukhvinder Singh Sukhu, the department of Industries held preparatory ...

Ahmedabad: The infrastructure work at the ambitious bulk drug park at Jambusar is expected to be completed by the end of this year. The bulk drug park is being developed to decrease import dependence ...

India is net exporter of bulk drugs in FY24, but the country continues to be dependent on imports for many antibiotic active pharmaceutical ingredients (APIs) manufactured through fermentation, the ...

Shardul Nautiyal, Mumbai Thursday, January 8, 2026, 08:00 Hrs [IST] ...

SOLAN: With the Department of Pharmaceuticals Government of India declaring 2015 as the year of Active Pharmaceutical Ingredients API the pharmaceutical industry in the state is hopeful of receiving ...

Bulk drugs — also known as APIs — are the building blocks in making finished formulations of a medicine that are used by patients. Indian firms that make active pharmaceutical ingredients, or APIs, ...